Real-world outcomes of advanced NSCLC patients with common and uncommon/complex EGFR mutation profiles Published September 2019 Citation Riely, GJ, Lovly, CM, Messina, CGM, Bienert, S, Alexander, K, Pao, W, Magee, K, Baxi, SS, Doebele, RC. . World Conference on Lung Cancer. . Authors:Riely, GJ, Lovly, CM, Messina, CGM, Bienert, S, Alexander, K, Pao, W, Magee, K, Baxi, SS, Doebele, RC Sources:World Conference on Lung Cancer Share Posted inPublicationsUnmet need More publicationsASCO GUFebruary 2026Persistent gaps in BRCA mutation testing among mCRPC patients: Insights from US cancer practices (2018–2024)McKay R, Li W, Roose J, et al.Publication summaryPublicationsProstate cancerASCO GUFebruary 2026Treatment patterns and survival outcomes among lutetium 177-experienced patients with metastatic castration-resistant prostate cancertran B, Dorff T, Richey M, et al.Publication summaryPublicationsProstate cancerASCO GUFebruary 2026Opportunities for precision oncology: Real-world patterns and disparities in FGFR3 testing among US patients with locally advanced/metastatic urothelial cancerSmyth E, Richey M, Patel K, et al. Publication summaryPublicationsUrothelial cell carcinoma